Victoria L. Creamer
Known title: EVP & Chief People OfficerCIK: 0001632780
Associated companies
Transaction History
| CRL | ▲ Buy | Option Exercise | 4,179 | $751K | 8/6/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 4,179 | $1.1M | 8/6/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 194 | $35K | 5/31/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 616 | $111K | 5/30/2026 | View on chart |
| CRL | ▲ Buy | Grant | 5,135 | $928K | 5/29/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 148 | $23K | 5/27/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 198 | $32K | 5/26/2026 | View on chart |
| CRL | ▲ Buy | Grant | 5,006 | $0 | 1/30/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 1,296 | $274K | 1/30/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 120 | $16K | 5/31/2025 | View on chart |
| CRL | ▲ Buy | Grant | 6,252 | $848K | 5/30/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 62 | $9K | 5/28/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 91 | $12K | 5/27/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 123 | $17K | 5/26/2025 | View on chart |
| CRL | ▲ Buy | Grant | 2,468 | $0 | 1/31/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 791 | $131K | 1/31/2025 | View on chart |
| CRL | ▲ Buy | Grant | 1,967 | $0 | 5/31/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 190 | $41K | 5/29/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 77 | $17K | 5/28/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 122 | $26K | 5/27/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 180 | $39K | 5/26/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 5,000 | $1.3M | 2/29/2024 | View on chart |
| CRL | ▲ Buy | Grant | 2,997 | $0 | 1/29/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 953 | $210K | 1/29/2024 | View on chart |
| CRL | ▲ Buy | Option Exercise | 3,381 | $489K | 12/14/2023 | View on chart |
| CRL | ▲ Buy | Option Exercise | 2,145 | $266K | 12/14/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 5,526 | $1.2M | 12/14/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 190 | $37K | 5/29/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 115 | $22K | 5/28/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 170 | $33K | 5/27/2023 | View on chart |
| CRL | ▲ Buy | Grant | 2,009 | $0 | 5/26/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 181 | $44K | 2/22/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 343 | $85K | 2/1/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 2,692 | $658K | 1/31/2023 | View on chart |
| CRL | ▲ Buy | Grant | 7,229 | $0 | 1/27/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 190 | $46K | 5/29/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 114 | $28K | 5/28/2022 | View on chart |
| CRL | ▲ Buy | Grant | 1,493 | $0 | 5/27/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 180 | $53K | 2/22/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 343 | $113K | 2/1/2022 | View on chart |
| CRL | ▲ Buy | Grant | 6,302 | $0 | 1/28/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 2,395 | $748K | 1/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
CRL Analyst Targets Rise After UBS Reinstates Coverage
Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.
CRL Analyst Targets Rise After UBS Reinstates Coverage. Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.